Skip to main content
Signal8
Launch Terminal
Shekhat Denil Nanji profile photo

Denil Nanji Shekhat

CIK: 0002016605

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MIRA PHARMACEUTICALS, INC. logo
MIRA

MIRA PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • MIRA PHARMACEUTICALS, INC. logo
    MIRA

    MIRA PHARMACEUTICALS, INC.

    Jun 12, 2026
    Award(A)

    Stock Options (right to buy)

    Direct
    50K shares-
  • MIRA PHARMACEUTICALS, INC. logo
    MIRA

    MIRA PHARMACEUTICALS, INC.

    Oct 1, 2025
    Award(A)
    Direct
    22.4K shares at avg. $1.35$30K
  • MIRA PHARMACEUTICALS, INC. logo
    MIRA

    MIRA PHARMACEUTICALS, INC.

    Dec 9, 2024
    Award(A)

    Stock Options (right to buy)

    Direct
    50K shares-

1-3 of 3

About Shekhat Denil Nanji

Shekhat Denil Nanji (SEC CIK 0002016605) files insider reports with the SEC as Director of MIRA PHARMACEUTICALS, INC. (MIRA).

Signal8 holds 3 ownership filings by Shekhat Denil Nanji, all Form 4s, filed between Dec 10, 2024 and Jun 15, 2026. Those filings report 3 transactions, from Dec 9, 2024 to Jun 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Shekhat Denil Nanji's filings is in MIAMI, FL.

Recent filings by Shekhat Denil Nanji

  • Jun 12, 2026: Grant or award of MIRA derivative securities (Form 4, code A).
  • Oct 1, 2025: Grant or award of MIRA shares (Form 4, code A).
  • Dec 9, 2024: Grant or award of MIRA derivative securities (Form 4, code A).

Other insiders filing for MIRA PHARMACEUTICALS, INC. (MIRA)

How to read Form 4 transaction codes